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Abstract: Perilymphatic atrophy can be a complication of intralesional corti-
costeroid injections given for the treatment of conditions such as psoriasis,
alopecia areata, and keloids, and intraarticular corticosteroid injections given
in diseases such as rheumatoid arthritis. It may become manifest as perile-
sional linear, depigmented, atrophic streaks, which are usually most prominent
in patients with dark-colored skin.
Numerous cutaneous changes have been re-
ported after systemic and local corticosteroid admin-
istration (1, 2), for example, local atrophy of the
skin and subcutaneous tissue. Linear atrophic
streaks, presumed to be atrophy of the dermis over-
lying lymphatic vessels draining the injection site,
were reported after intralesional corticosteroid in-
jections into a lesion of alopecia areata (3, 4) and
keloid (4, 5), and intraarticular injections into knees
(6), This report may promote more frequent recog-
nition of this side effect, which should be kept in
mind when intralesional corticosteroid injections
are given in psoriasis and other diseases.
CASE REPORT
A 15-year-old black girl was first seen by us in June
1986 for the evaluation of a lesion on the lateral as-
pect of her left foot that had been present for the
last several months. Previous treattnents included
three intralesional corticosteroid injections (triam-
cjnolone, 2.5 mg/mi) as well as topical corticoste-
roids. resulting in a moderate response.
On examination, on the lateral aspect of her left
foot was a well-demarcated, erythematous, scaly
plaque, approximately 4 x 1.5 cm in diameter (Fig,
1), No other cutaneous lesions were present else-
where. Clinically, the diagnosis was psoriasis. From
the anterosuperior edge of the plaque, an inverted
Y-shaped streak of atrophy with depigmentation
was noted. A vertical streak was also present over
posterosuperior aspect of the plaque (Fig, 1). The
former was 8 mm wide and the combined length of
the three links of the Y-shaped streak was approxi-
mately 9 cm. The latter was 1.2 cm wide and 4 cm
long.
The patient was otherwise in good health and
was taking no medication. There was no feimily his-
tory of psoriasis or other cutaneous disease. When
seen in follow-up six weeks later, the perilesional
streaks were almost completely resolved.
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Figure 1 , Psoriatic plaque on the lateral aspect of the left
foot. Along the anterosuperior and posterosuperior bor-
ders there are streaks of atrophy and depigmentation.
COMMENT
Two pronounced, depressed streaks developed in a
patient with alopecia areata after two or three in-
tralesional injections of corticosteroids (3). It was
assumed that the corticosteroid was transmitted by
the lymphatic vessels.
Linear atrophy was described extending distal ly
on the forehead starting from a lesion of alopecia
areata into which intradermal corticosteroids had
been injected (4). Upon injection of local anesthetic
prior to obtaining a biopsy specimen, the atrophic
line disappeared. When Evan blue was injected
along the atrophic line, it was found that a lym-
phatic vessel lay in the same path.
Linear atrophy was reported after intraiesional
injections of triamcinolone in a keloid located on an
arm (5). A Y-shaped lesion with a total length of 17
cm developed, starting at the proximal and distal as-
pects of the keloid. Alphazurine 2G (patent blue)
was injected at two points along the atrophic line
using the same technique as that employed to find
a lymphatic vessel during lymphangiography. The
atrophic line ran along the course of the vessel,
which stained blue at both points. Histologic ex-
amination showed the stained vessel to be atonic
and partly lined by cuboidal cells. These points
wereinfavorof the vessel being lymphatic in origin.
Linear skin atrophy was associated with re-
peated intraarticular corticosteroid injections into
the knees of a patient with severe rheumatoid ar-
thritis (6), During a three-year period, approxi-
mately 40 injections of triamcinolone acetonide,
triamcinolone hexacetonide, dexamethasone ace-
tate, or methylprednisolone were administered to
both knees at various times. Generally, an intraar-
ticular injection of 20 to 40 mg of a triamcinolone
compound (or an equivalent amount of another cor-
ticosteroid) was given at any one time.
The atrophic perilesional streaks seen in our pa-
tient were associated with intralesional corticoste-
roid injections given to treat the plaque of psoriasis,
and resembled those appearing after the same form
of therapy as cited. Our patient declined to have a
biopsy or lymphangiogram. We speculate that the
perilesional atrophic streaks in our patient repre-
sented pedlymphatic atrophy, as in the other cases.
Fine suspension of corticosteroids is probably re-
moved by the perilesional lymphatics. If a high
enough intravascular corticosteroid concentration
is reached, this may predispose to perilymphatic
atrophy. This likely depends upon the number and
frequency of the intralesional injections and the po-
tency of corticosteroid used. Abnormal permeabil-
ity of perilesional lymphatics, present in association
with active disease in the lesion, could be a predis-
posing factor.
Peril ymphatic atrophy may be permanent, but
gradual resolution has been reported (3—5). In our
patient, when seen in follow-up six weeks later, the
perilesional atrophic streaks had almost disap-
peared.
This report should raise the index of suspicion
for perilymphatic atrophy when perilesional linear
atrophic streaks are noted after intralesional or in-
traarticular injections of corticosteroids. These may
be more prominent in patients who have a dark
complexion.
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